AC
SGMO

Amia Capital’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Amia Capital’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-21,018
Closed -$199K – 25
2020
Q3 		$199K Sell
21,018
-626
-3% -$6.77K 0.23% 31
2020
Q2 		$194K Sell
21,644
-11,911
-35% -$111K 0.16% 33
2020
Q1 		$214K Sell
33,555
-3,557
-10% -$26.4K 0.19% 35
2019
Q4 		$311K Buy
+37,112
New +$341K 0.09% 37

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Amia Capital's SGMO Position: Q4 2020 in Review

Amia Capital sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2020, closing a stake of 21,018 shares — an estimated $199K sold.

Amia Capital first reported a position in SGMO in Q4 2019 and held it in 4 quarters. The position peaked at $311K in Q4 2019. 223 funds tracked by Wall St. Rank hold SGMO as of Q4 2020.

  • Amia Capital reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2020 after selling out during the quarter.
  • Amia Capital sold 21,018 SANGAMO THERAPEUTICS INC shares in Q4 2020, an estimated $199K.
  • Amia Capital first reported a position in SANGAMO THERAPEUTICS INC in Q4 2019 and held it in 4 quarters.
  • Amia Capital's SANGAMO THERAPEUTICS INC position peaked at $311K in Q4 2019.
  • 223 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2020.

Based on Amia Capital's 13F filing for Q4 2020, filed 11 Feb 2021.